Cyclin-dependent kinase inhibitor, roscovitine, in combination with exogenous cytokinin, N6-benzyladenine, causes increase of cis-cytokinins in immobilized tobacco cells

Biotechnol Lett. 2003 Mar;25(6):469-72. doi: 10.1023/a:1022612905134.

Abstract

Dynamics of the response of tobacco cells (line BY-2) to exogenous cytokinin, N6-benzyladenine, and cyclin-dependent kinase inhibitor, roscovitine, was followed using alginate-immobilized cells packed into a column. N6-Benzyladenine (1.25 microM) increased the synthesis of the physiologically-active endogenous cytokinin, isopentenyladenosine, in the effluent up to 0.1 nM. Simultaneously, conversion of the excess of endogenous cytokinins to biologically inactive derivatives of cis-zeatin occurred, up to 0.8 nM. Roscovitine (50 microM) further increased cis-cytokinins, up to 2.2 nM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / pharmacology*
  • Alginates
  • Benzyl Compounds
  • Cell Survival
  • Cells, Cultured
  • Cells, Immobilized / drug effects
  • Cells, Immobilized / metabolism
  • Cyclin-Dependent Kinases / antagonists & inhibitors
  • Cytokinins / biosynthesis
  • Glucuronic Acid
  • Hexuronic Acids
  • Isopentenyladenosine / biosynthesis*
  • Kinetin
  • Nicotiana / drug effects*
  • Nicotiana / metabolism*
  • Purines / pharmacology*
  • Reproducibility of Results
  • Roscovitine
  • Sensitivity and Specificity

Substances

  • Alginates
  • Benzyl Compounds
  • Cytokinins
  • Hexuronic Acids
  • Purines
  • Roscovitine
  • Isopentenyladenosine
  • Glucuronic Acid
  • Cyclin-Dependent Kinases
  • Adenine
  • benzylaminopurine
  • Kinetin